Harfst & Associates Inc. Raises Holdings in Intuitive Surgical, Inc. $ISRG

Harfst & Associates Inc. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 122.6% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,019 shares of the medical equipment provider’s stock after purchasing an additional 1,663 shares during the quarter. Harfst & Associates Inc.’s holdings in Intuitive Surgical were worth $1,641,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the stock. Tobam increased its position in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares during the period. TD Capital Management LLC lifted its position in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares during the period. 1248 Management LLC purchased a new stake in Intuitive Surgical during the 1st quarter valued at about $30,000. Princeton Global Asset Management LLC acquired a new position in shares of Intuitive Surgical in the second quarter valued at about $30,000. Finally, Bank of Jackson Hole Trust raised its stake in shares of Intuitive Surgical by 70.5% in the first quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock worth $37,000 after purchasing an additional 31 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Myriam Curet sold 7,562 shares of the firm’s stock in a transaction dated Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66. Following the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $193,595.79. This trade represents a 95.54% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 116,164 shares of company stock worth $61,916,172. Company insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of several research reports. HSBC increased their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Robert W. Baird set a $655.00 target price on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. UBS Group set a $600.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Argus upped their target price on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.

Read Our Latest Stock Report on Intuitive Surgical

Intuitive Surgical Trading Down 0.8%

Shares of ISRG opened at $574.23 on Thursday. The firm has a market cap of $205.85 billion, a P/E ratio of 75.96, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The stock’s 50 day moving average is $500.48 and its two-hundred day moving average is $504.89.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business’s revenue was up 22.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.84 EPS. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.